Abstract
The main objective of this research is to perform and supervise radiopharmacy studies related to developing the in house labeling of the fibroblast activation protein (FAPI) molecule first with gallium-68 and then with lutetium-177 for FAPITher for theranostic.This process will include the validation of the synthesis process and quality control of the final product and the evaluation of t…